[HTML][HTML] Paradoxical response in a patient with non-small cell lung cancer who received nivolumab followed by anti-Mycobacterium tuberculosis agents
S Takata, G Koh, Y Han, H Yoshida… - Journal of Infection and …, 2019 - Elsevier
Anti-programmed cell death-1 (PD-1) agents enhance the antitumor immunoresponse. A
number of reports have indicated that patients with malignancies who receive anti-PD-1 agents …
number of reports have indicated that patients with malignancies who receive anti-PD-1 agents …
[HTML][HTML] Prompt reduction in CRP, IL-6, IFN-γ, IP-10, and MCP-1 and a relatively low basal ratio of ferritin/CRP is possibly associated with the efficacy of tocilizumab …
…, Y Tamura, H Morishita, H Matsuoka, Y Han… - Frontiers in …, 2021 - frontiersin.org
Background and Aim: Tocilizumab, a humanized anti-IL-6 receptor antibody, has been used
to treat severely to critically ill patients with COVID-19. A living systematic review with meta-…
to treat severely to critically ill patients with COVID-19. A living systematic review with meta-…
[HTML][HTML] Efficacy and safety of concurrent anti-Cancer and anti-tuberculosis chemotherapy in Cancer patients with active Mycobacterium tuberculosis: a retrospective …
T Hirashima, Y Tamura, Y Han, S Hashimoto, A Tanaka… - BMC cancer, 2018 - Springer
Background In our previous study, colorectal cancer (CRC) patients with active Mycobacterium
tuberculosis (MTB) tolerated concurrent anti-cancer chemotherapy (anti-CCT) and anti-…
tuberculosis (MTB) tolerated concurrent anti-cancer chemotherapy (anti-CCT) and anti-…
Rapid serodiagnosis of human mycobacteriosis by ELISA using cord factor (trehalose-6,6′-dimyclate) purified from Mycobacterium tuberculosis as antigen
H He, S Oka, Y Han, Y Yamamura… - FEMS microbiology …, 1991 - academic.oup.com
IgG antibodies against purified cord factor (trehalose-6,6′-dimycolate, TDM) in sera of 99
patients infected with mycobacteria (42 patients with tuberculosis excreting tubercle bacilli in …
patients infected with mycobacteria (42 patients with tuberculosis excreting tubercle bacilli in …
Scoring system for identifying Japanese patients with COVID-19 at risk of requiring oxygen supply: A retrospective single-center study
…, H Morishita, H Matsuoka, Y Kashiwa, Y Han… - Journal of Infection and …, 2021 - Elsevier
Introduction Japan is facing the threat of medical system collapse due to the rapid spread of
coronavirus disease 2019 (COVID-19). The present scoring system may help assess …
coronavirus disease 2019 (COVID-19). The present scoring system may help assess …
Enzyme-linked immunosorbent assay (ELISA) using a glycolipid antigen for the serodiagnosis of melioidosis
L Van Phung, Y Han, S Oka, H Hotta… - FEMS Immunology & …, 1995 - academic.oup.com
The serodiagnosis of melioidosis is commonly performed with tests using protein or
polysaccharide as antigen. However, due to the low sensitivity, specificity and difficulty in the …
polysaccharide as antigen. However, due to the low sensitivity, specificity and difficulty in the …
Treatment outcome of patients with multidrug-resistant pulmonary tuberculosis during pregnancy
…, Y Tamura, T Nagai, T Matsumoto, Y Han… - Kekkaku …, 2006 - jstage.jst.go.jp
[目的] 妊婦多剤耐性肺結核に対する二次抗結核薬を中心とした化学療法の有効性と安全性の検討.[対象
と方法] 大阪府立呼吸器・アレルギー医療センターにおいて妊娠中に多剤耐性肺結核と診断…
と方法] 大阪府立呼吸器・アレルギー医療センターにおいて妊娠中に多剤耐性肺結核と診断…
Comparative study of the efficacy of the COBAS TaqMan and LAMP assay for the rapid diagnosis of tuberculosis
…, T Tazawa, Y Tsurinaga, M Kurokawa, Y Han… - Kekkaku …, 2013 - europepmc.org
OBJECTIVE; The COBAS TaqMan real-time polymerase chain reaction (PCR) assay (TaqMan
assay) is a well-accepted and widely distributed molecular-based diagnostic test for …
assay) is a well-accepted and widely distributed molecular-based diagnostic test for …
A retrospective study evaluating efficacy and safety of compassionate use of tocilizumab in 13 patients with severe-to-critically ill COVID-19: analysis of well …
…, Y Tamura, T Nagai, H Morishita, H Matsuoka, Y Han… - medRxiv, 2020 - medrxiv.org
We administered tocilizumab into 13 severe-to-critically ill patients with coronavirus disease
2019 (COVID-19) for compassionate use in combination with potential anti-viral agents in …
2019 (COVID-19) for compassionate use in combination with potential anti-viral agents in …
Effect of ipriflavone on bone mineral density of lumbar spine of aged women
…, K Nakatsuka, Y Nishizawa, K Iba, Y Han… - Journal of Bone and …, 1993 - Springer
Aged women with osteoporosis were followed for 6 months with or without ipriflavone (IP)
600 mg/day, and lumbar bone mineral density (BMD) and bone mineral content (BMC) were …
600 mg/day, and lumbar bone mineral density (BMD) and bone mineral content (BMC) were …